Not which Indian stocks Jhunjhunwala owned, but the three repeatable habits behind them: pick a structural growth tailwind first, buy quality inside it even at a fair price, and hold quietly until a rare dislocation justifies a heavy swing.
1. Start from a structural tailwind, then buy the companies that sit directly on it
The repeatable method
- Name the demand driver in plain terms and check it is multi-decade, not cyclical — here population growth, rising consumer spending and infrastructure build-out.
- List the categories where that driver shows up as spending (discretionary retail, insurance penetration, vehicles).
- Within each, own the leader with the brand or distribution to capture the growth — then hold "for years. Sometimes, even decades."
Here: "Never short India." A richer middle class became jewellery and watches (TITAN.NS), health cover (STARHEALTH.NS) and cars (TMPV.NS). (Principle 1, Portfolio.)
Watch for
- Evidence the tailwind is intact at the category level: retail market size, insurance penetration, per-capita income — not just headline GDP growth.
- A tailwind the whole market already agrees on gets priced in; the edge in this story was holding through decades, not spotting India.
2. Be a value buyer who will still pay up for a scalable business with excellent management
The repeatable method
- Default to buying below intrinsic value.
- Make one exception: a "wonderful company with excellent management" and a scalable model that can "grow big and crush their competition" is worth a fair price or a premium.
- Judge the exception on durability of the lead (brand trust, market position, parent/management quality), because the payoff comes from how long it compounds, not from the entry multiple.
Here: TITAN.NS — "a powerful brand, leading positions in its markets, and outstanding management backed by the Tata Group" — held 20+ years for ~700x: "You only need one investment like this." (Principle 2, Titan.)
Watch for
- The exception creeping into everything: if most holdings were bought "at a premium," the value discipline is gone.
- Signs the lead is eroding — share loss to organised rivals, or management change at the parent.
3. Wait patiently, then size up hard when a rare dislocation appears
The repeatable method
- Most of the time, do nothing: "real wealth doesn't come from trading every day."
- Keep a list of businesses you'd own on a structural thesis, so a crash is a buying list, not a panic.
- When a market-wide shock pushes one of them far below its recovery value, "act fast" and "swing heavily."
- Separately, look for pre-IPO or early entries into a growing category before the public market prices it.
Here: TMPV.NS bought in the 2020 COVID crash, 5x and $71.6m; STARHEALTH.NS bought pre-IPO, $114m → $859m. The net-worth chart shows the pattern — ~₹8,400 cr at the March 2020 low, ~₹38,700 cr by mid-2023. (Principle 3, Performance, Portfolio.)
Watch for
- A broad, indiscriminate sell-off hitting a name whose long-term thesis hasn't changed — that's the setup; a company-specific collapse is not.
- Heavy swings in cyclical, capital-hungry businesses (car-makers) need a recovery catalyst, not just cheapness.
4. Check a famous track record before borrowing its lessons
The repeatable method
- Recompute the headline CAGR from the stated start and end values and years.
- Ask whether the figure is a portfolio return or a net-worth change (which includes leverage, trading, private deals and currency).
- Check the survivorship: the profile is written because the investor became a billionaire; the same habits followed by others did not all end that way.
Here: the post quotes both 62% and 65% a year; $100 → $5.8bn over 37 years is ~62%. It is a net-worth figure that started in derivatives trading and includes a ₹-to-$ conversion over four decades. (Intro, Performance.)
Watch for
- Two different return numbers for the same record in one piece.
- Charts that run past the event they illustrate (the net-worth series continues after his 2022 death).
Methods distilled from the archived Compounding Quality post for personal study. Not investment advice.